Serum Institute to produce Sputnik V vaccine from September
As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab. After the approval by the Drug Controller General of India (DCGI), the cultivation process has begun.
Jul 13, 2021, 15:56 PM IST